Research

Studio City Life Magazine: Charity Spotlight

May 1, 2024 Comments Off on Studio City Life Magazine: Charity Spotlight

The May 2024 issue of Studio City Life Magazine featured ALS Network president and CEO Sheri Strahl, along with ALS Network Advisory Trustee Dr. Richard Smith. Readers received details on…

Celebrating Collaboration: the 2024 Death Valley Ride to Cure ALS

April 24, 2024 Comments Off on Celebrating Collaboration: the 2024 Death Valley Ride to Cure ALS

On April 9, Jaime Lafita, a native of Bilbao, Spain, who has been living with amyotrophic lateral sclerosis (ALS) since 2016, started his journey of the Death Valley Ride to…

Celebrating the 2024 Sheila Essey Award Winner

April 15, 2024 Comments Off on Celebrating the 2024 Sheila Essey Award Winner

Eva Feldman, M.D., Ph.D., FAAN, has been named the 2024 recipient of the Sheila Essey Award for ALS Research. Dr. Feldman has dedicated her career to studying neurodegenerative diseases and…

New ALS Research and Moonshot Era

April 4, 2024 Comments Off on New ALS Research and Moonshot Era

A trailblazer in the field of ALS research and therapy development, Richard Smith, MD, director of the Center for Neurologic Study, and a member of the ALS Network’s scientific review…

Mechanisms of ALS Medications

March 29, 2024 Comments Off on Mechanisms of ALS Medications

In January 2024, Jill Ann Goslinga, MD, MPH, Assistant Professor, UCSF Department of Neurology, gave a special presentation about the mechanisms of ALS medications at the ALS Network’s (formerly the…

BrainStorm Cell Therapeutics

Phase 3b Trial Design Unveiled at Clinical/Scientific Conference

February 27, 2024 Comments Off on Phase 3b Trial Design Unveiled at Clinical/Scientific Conference

Planned Phase 3b trial Designed to Confirm Efficacy and Safety of NurOwn in mild-to-moderate ALS patients NEW YORK, Feb. 27, 2024 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer…

2024 Barber ALS Research Award Winners

January 30, 2024 Comments Off on 2024 Barber ALS Research Award Winners

Notable ALS advocate Jim Barber was an instrumental voice in the ALS community who advocated for ALS research. A major outcome of his work was the formation of the California…

Highlights of the 14th Annual California ALS Research Summit

January 30, 2024 Comments Off on Highlights of the 14th Annual California ALS Research Summit

The 14th annual California ALS Research Summit was a seminal event in the world of ALS research and care, with over 200 researchers, investigators, clinicians, biotech companies, partner organizations, and…

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

December 7, 2023 Comments Off on BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

NEW YORK, Dec. 7, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the completion of a productive…

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

October 24, 2023 Comments Off on BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

–  Resource consumption will be reduced by 50% to accelerate ALS development –  Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS NEW YORK, Oct. 24,…